Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement
Clinical trial NCT05391607 · COMPLETED
Trial details
- NCT number
- NCT05391607
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2023-03-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.